[go: up one dir, main page]

NO993407L - Preparation of protein preparations with reduced aggregate content - Google Patents

Preparation of protein preparations with reduced aggregate content

Info

Publication number
NO993407L
NO993407L NO993407A NO993407A NO993407L NO 993407 L NO993407 L NO 993407L NO 993407 A NO993407 A NO 993407A NO 993407 A NO993407 A NO 993407A NO 993407 L NO993407 L NO 993407L
Authority
NO
Norway
Prior art keywords
preparation
aggregate content
protein preparations
reduced aggregate
preparations
Prior art date
Application number
NO993407A
Other languages
Norwegian (no)
Other versions
NO993407D0 (en
Inventor
Verena Foertsch
Kurt Reichen
Peter G Lerch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of NO993407D0 publication Critical patent/NO993407D0/en
Publication of NO993407L publication Critical patent/NO993407L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Oppfinnelsen angår en fremgangsmåte for fremstilling av proteinpreparater med redusert aggregatinnhold, særlig fremstilling av medisinske preparater fra blodplasmaprotein som f.eks. albumin.BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to a process for the preparation of protein preparations having a reduced aggregate content, in particular to the preparation of medical preparations from blood plasma protein, e.g. albumin.

NO993407A 1998-07-10 1999-07-09 Preparation of protein preparations with reduced aggregate content NO993407L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1998131061 DE19831061A1 (en) 1998-07-10 1998-07-10 Reducing aggregate content of protein preparation, especially virus-inactivated therapeutic plasma protein or chemically modified protein preparation

Publications (2)

Publication Number Publication Date
NO993407D0 NO993407D0 (en) 1999-07-09
NO993407L true NO993407L (en) 2000-01-11

Family

ID=7873695

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993407A NO993407L (en) 1998-07-10 1999-07-09 Preparation of protein preparations with reduced aggregate content

Country Status (6)

Country Link
EP (1) EP0976759A3 (en)
JP (1) JP2000053581A (en)
AU (1) AU3676599A (en)
CA (1) CA2277406A1 (en)
DE (1) DE19831061A1 (en)
NO (1) NO993407L (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365395B1 (en) * 2000-11-03 2002-04-02 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
JPWO2004089402A1 (en) * 2003-04-09 2006-07-06 財団法人化学及血清療法研究所 Method for producing albumin preparation
JP2006182649A (en) * 2003-04-09 2006-07-13 Chemo Sero Therapeut Res Inst Method for removing albumin aggregate and/or contaminated protein
ES2392061T3 (en) 2003-12-22 2012-12-04 Regentis Biomaterials Ltd. Matrix comprising a crosslinked naturally occurring protein skeleton
US7842667B2 (en) 2003-12-22 2010-11-30 Regentis Biomaterials Ltd. Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
ES2294976B1 (en) * 2007-11-12 2008-12-16 Grifols, S.A. "HIGH EFFECTIVE HUMAN ALBUMIN OBTAINING PROCEDURE FOR USE IN DETOXIFICATION THERAPY".
WO2017084682A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal carbon dioxide removal
WO2017084683A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal lung support
AU2016398366B2 (en) 2016-03-14 2022-04-14 Advitos Gmbh Systems or apparatuses and methods for performing dialysis
CN110520136A (en) * 2017-03-28 2019-11-29 阿德维托斯有限公司 For making the regenerated composition of multi-way albumin dialysis liquid and method containing carrier protein
AU2018273106A1 (en) 2017-05-22 2019-12-19 Advitos Gmbh Methods and systems for removing carbon dioxide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156681A (en) * 1974-03-28 1979-05-29 Plasmesco Ag Process for isolating albumin from blood
DE3641115A1 (en) * 1986-12-02 1988-06-16 Lentia Gmbh METHOD FOR PRODUCING AN INTRAVENOUS APPLICABLE AND STABLE IN LIQUID FORM IMMUNOGLOBULINS
FR2648048B1 (en) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine PROCESS FOR THE PREPARATION OF PURIFIED ALBUMIN SOLUTIONS
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same

Also Published As

Publication number Publication date
EP0976759A3 (en) 2002-08-14
DE19831061A1 (en) 2000-01-13
CA2277406A1 (en) 2000-01-10
AU3676599A (en) 2000-06-22
JP2000053581A (en) 2000-02-22
NO993407D0 (en) 1999-07-09
EP0976759A2 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
DK1200418T3 (en) Nematodicidal trifluorobutene
BR0108713A (en) Hybrid Expression of Neisserial Proteins
BG101118A (en) Therapeutical compounds
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
HUP9700603A1 (en) Medicinal preparation for the treatment of blood clotting disorders
NO971889L (en) Compounds and compositions for delivery of active agents
NO20030374D0 (en) Cyclopentanoindoles, preparations containing such compounds and treatment methods
NO954320D0 (en) Lyospheres comprising gonadotropin
EA199901031A1 (en) Derivatives of benzimidazole
EE05091B1 (en) Oligosaccharides, process for their preparation and use, and pharmaceutical compositions
IT1293778B1 (en) 1,4,7,10-TETRAAZABICICLO (8.2.2.)TETRADECAN-2 ONE, ITS PREPARATION AND USE FOR THE PREPARATION OF TETRAAZAMACROCYCLES
NO993407L (en) Preparation of protein preparations with reduced aggregate content
DE60141301D1 (en) AROMA CONCENTRATE
PL374080A1 (en) Processes for the preparation of fibrinogen
CA2531419C (en) Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
BR9915460A (en) Method of treatment of viral hemorrhagic fever
PT1107793E (en) DEXTRANE-LEPTIN CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND RELATED PROCESSES
WO2002068475A3 (en) Pharmaceutical composition of f(ab)2 fragments of antibodies and method for the preparation thereof
EA199700243A1 (en) AMINOTHETRALINE DERIVATIVE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
EA200000875A1 (en) PROTEINS INTERACTING WITH CASPASE-8
NO992531L (en) Methods of producing recombinant protein
SE8402199L (en) PHARMACEUTICAL PREPARATION CONTAINING CO-DERGOCRIN AND A CALCIUM ANTAGONIST
MD1473G2 (en) Antiherpetic remedy
SE9803107D0 (en) Novel Compunds
PT1408035E (en) METHOD FOR THE PREPARATION OF DERIVATIVES OF 1,5-DIARIL-3-TRIFLUOROMETHYL-DELTA2-PYRAZOLINS THAT ARE RACERICALLY AND ENHANCERLY PURE